SMS Pharmaceuticals Limited (SMSPHARMA.NS)
- Previous Close
262.55 - Open
263.99 - Bid --
- Ask --
- Day's Range
259.01 - 264.99 - 52 Week Range
175.25 - 398.00 - Volume
62,883 - Avg. Volume
161,001 - Market Cap (intraday)
23.274B - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
33.57 - EPS (TTM)
7.82 - Earnings Date May 27, 2025 - May 31, 2025
- Forward Dividend & Yield 0.40 (0.15%)
- Ex-Dividend Date Sep 23, 2024
- 1y Target Est
--
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
smspharma.com1,197
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: SMSPHARMA.NS
View MorePerformance Overview: SMSPHARMA.NS
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMSPHARMA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMSPHARMA.NS
View MoreValuation Measures
Market Cap
23.26B
Enterprise Value
25.91B
Trailing P/E
33.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.85
Price/Book (mrq)
4.13
Enterprise Value/Revenue
3.33
Enterprise Value/EBITDA
18.85
Financial Highlights
Profitability and Income Statement
Profit Margin
8.47%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
7.8B
Net Income Avi to Common (ttm)
660.99M
Diluted EPS (ttm)
7.82
Balance Sheet and Cash Flow
Total Cash (mrq)
90.66M
Total Debt/Equity (mrq)
50.63%
Levered Free Cash Flow (ttm)
--